Global Newcastle Disease Vaccine Market Analysis and Forecast 2024-2030
Summary
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
According to APO Research, The global Newcastle Disease Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Newcastle Disease Vaccine include Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN and Zoetis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Newcastle Disease Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Newcastle Disease Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Newcastle Disease Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Newcastle Disease Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Newcastle Disease Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Newcastle Disease Vaccine sales, projected growth trends, production technology, application and end-user industry.
Newcastle Disease Vaccine segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Newcastle Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Newcastle Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Newcastle Disease Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Newcastle Disease Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Newcastle Disease Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
According to APO Research, The global Newcastle Disease Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Newcastle Disease Vaccine include Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN and Zoetis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Newcastle Disease Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Newcastle Disease Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Newcastle Disease Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Newcastle Disease Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Newcastle Disease Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Newcastle Disease Vaccine sales, projected growth trends, production technology, application and end-user industry.
Newcastle Disease Vaccine segment by Company
- Merial
- CEVA
- QYH Biotech
- Ringpu Biology
- Yebio
- Harbin Veterinary Research Institute
- Merck Animal Health
- DHN
- Zoetis
- ChengDu Tecbond
- Elanco (Lohmann)
- FATRO
- CAVAC
- Vaksindo
- Live Vaccines
- Killed Vaccines
- Chicken
- Duck & Goose
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Newcastle Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Newcastle Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Newcastle Disease Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Newcastle Disease Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Newcastle Disease Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Newcastle Disease Vaccine Market by Type
1.2.1 Global Newcastle Disease Vaccine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Newcastle Disease Vaccine Market by Application
1.3.1 Global Newcastle Disease Vaccine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 NEWCASTLE DISEASE VACCINE MARKET DYNAMICS
2.1 Newcastle Disease Vaccine Industry Trends
2.2 Newcastle Disease Vaccine Industry Drivers
2.3 Newcastle Disease Vaccine Industry Opportunities and Challenges
2.4 Newcastle Disease Vaccine Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Newcastle Disease Vaccine Revenue Estimates and Forecasts (2019-2030)
3.2 Global Newcastle Disease Vaccine Revenue by Region
3.2.1 Global Newcastle Disease Vaccine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Newcastle Disease Vaccine Revenue by Region (2019-2024)
3.2.3 Global Newcastle Disease Vaccine Revenue by Region (2025-2030)
3.2.4 Global Newcastle Disease Vaccine Revenue Market Share by Region (2019-2030)
3.3 Global Newcastle Disease Vaccine Sales Estimates and Forecasts 2019-2030
3.4 Global Newcastle Disease Vaccine Sales by Region
3.4.1 Global Newcastle Disease Vaccine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Newcastle Disease Vaccine Sales by Region (2019-2024)
3.4.3 Global Newcastle Disease Vaccine Sales by Region (2025-2030)
3.4.4 Global Newcastle Disease Vaccine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Newcastle Disease Vaccine Revenue by Manufacturers
4.1.1 Global Newcastle Disease Vaccine Revenue by Manufacturers (2019-2024)
4.1.2 Global Newcastle Disease Vaccine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Newcastle Disease Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Newcastle Disease Vaccine Sales by Manufacturers
4.2.1 Global Newcastle Disease Vaccine Sales by Manufacturers (2019-2024)
4.2.2 Global Newcastle Disease Vaccine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Newcastle Disease Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Newcastle Disease Vaccine Sales Price by Manufacturers (2019-2024)
4.4 Global Newcastle Disease Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Newcastle Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Newcastle Disease Vaccine Manufacturers, Product Type & Application
4.7 Global Newcastle Disease Vaccine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Newcastle Disease Vaccine Market CR5 and HHI
4.8.2 2023 Newcastle Disease Vaccine Tier 1, Tier 2, and Tier
5 NEWCASTLE DISEASE VACCINE MARKET BY TYPE
5.1 Global Newcastle Disease Vaccine Revenue by Type
5.1.1 Global Newcastle Disease Vaccine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Newcastle Disease Vaccine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Newcastle Disease Vaccine Revenue Market Share by Type (2019-2030)
5.2 Global Newcastle Disease Vaccine Sales by Type
5.2.1 Global Newcastle Disease Vaccine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Newcastle Disease Vaccine Sales by Type (2019-2030) & (M Doses)
5.2.3 Global Newcastle Disease Vaccine Sales Market Share by Type (2019-2030)
5.3 Global Newcastle Disease Vaccine Price by Type
6 NEWCASTLE DISEASE VACCINE MARKET BY APPLICATION
6.1 Global Newcastle Disease Vaccine Revenue by Application
6.1.1 Global Newcastle Disease Vaccine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Newcastle Disease Vaccine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Newcastle Disease Vaccine Revenue Market Share by Application (2019-2030)
6.2 Global Newcastle Disease Vaccine Sales by Application
6.2.1 Global Newcastle Disease Vaccine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Newcastle Disease Vaccine Sales by Application (2019-2030) & (M Doses)
6.2.3 Global Newcastle Disease Vaccine Sales Market Share by Application (2019-2030)
6.3 Global Newcastle Disease Vaccine Price by Application
7 COMPANY PROFILES
7.1 Merial
7.1.1 Merial Comapny Information
7.1.2 Merial Business Overview
7.1.3 Merial Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Merial Newcastle Disease Vaccine Product Portfolio
7.1.5 Merial Recent Developments
7.2 CEVA
7.2.1 CEVA Comapny Information
7.2.2 CEVA Business Overview
7.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 CEVA Newcastle Disease Vaccine Product Portfolio
7.2.5 CEVA Recent Developments
7.3 QYH Biotech
7.3.1 QYH Biotech Comapny Information
7.3.2 QYH Biotech Business Overview
7.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 QYH Biotech Newcastle Disease Vaccine Product Portfolio
7.3.5 QYH Biotech Recent Developments
7.4 Ringpu Biology
7.4.1 Ringpu Biology Comapny Information
7.4.2 Ringpu Biology Business Overview
7.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
7.4.5 Ringpu Biology Recent Developments
7.5 Yebio
7.5.1 Yebio Comapny Information
7.5.2 Yebio Business Overview
7.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Yebio Newcastle Disease Vaccine Product Portfolio
7.5.5 Yebio Recent Developments
7.6 Harbin Veterinary Research Institute
7.6.1 Harbin Veterinary Research Institute Comapny Information
7.6.2 Harbin Veterinary Research Institute Business Overview
7.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
7.6.5 Harbin Veterinary Research Institute Recent Developments
7.7 Merck Animal Health
7.7.1 Merck Animal Health Comapny Information
7.7.2 Merck Animal Health Business Overview
7.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
7.7.5 Merck Animal Health Recent Developments
7.8 DHN
7.8.1 DHN Comapny Information
7.8.2 DHN Business Overview
7.8.3 DHN Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 DHN Newcastle Disease Vaccine Product Portfolio
7.8.5 DHN Recent Developments
7.9 Zoetis
7.9.1 Zoetis Comapny Information
7.9.2 Zoetis Business Overview
7.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Zoetis Newcastle Disease Vaccine Product Portfolio
7.9.5 Zoetis Recent Developments
7.10 ChengDu Tecbond
7.10.1 ChengDu Tecbond Comapny Information
7.10.2 ChengDu Tecbond Business Overview
7.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
7.10.5 ChengDu Tecbond Recent Developments
7.11 Elanco (Lohmann)
7.11.1 Elanco (Lohmann) Comapny Information
7.11.2 Elanco (Lohmann) Business Overview
7.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
7.11.5 Elanco (Lohmann) Recent Developments
7.12 FATRO
7.12.1 FATRO Comapny Information
7.12.2 FATRO Business Overview
7.12.3 FATRO Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 FATRO Newcastle Disease Vaccine Product Portfolio
7.12.5 FATRO Recent Developments
7.13 CAVAC
7.13.1 CAVAC Comapny Information
7.13.2 CAVAC Business Overview
7.13.3 CAVAC Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 CAVAC Newcastle Disease Vaccine Product Portfolio
7.13.5 CAVAC Recent Developments
7.14 Vaksindo
7.14.1 Vaksindo Comapny Information
7.14.2 Vaksindo Business Overview
7.14.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 Vaksindo Newcastle Disease Vaccine Product Portfolio
7.14.5 Vaksindo Recent Developments
8 NORTH AMERICA
8.1 North America Newcastle Disease Vaccine Market Size by Type
8.1.1 North America Newcastle Disease Vaccine Revenue by Type (2019-2030)
8.1.2 North America Newcastle Disease Vaccine Sales by Type (2019-2030)
8.1.3 North America Newcastle Disease Vaccine Price by Type (2019-2030)
8.2 North America Newcastle Disease Vaccine Market Size by Application
8.2.1 North America Newcastle Disease Vaccine Revenue by Application (2019-2030)
8.2.2 North America Newcastle Disease Vaccine Sales by Application (2019-2030)
8.2.3 North America Newcastle Disease Vaccine Price by Application (2019-2030)
8.3 North America Newcastle Disease Vaccine Market Size by Country
8.3.1 North America Newcastle Disease Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Newcastle Disease Vaccine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Newcastle Disease Vaccine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Newcastle Disease Vaccine Market Size by Type
9.1.1 Europe Newcastle Disease Vaccine Revenue by Type (2019-2030)
9.1.2 Europe Newcastle Disease Vaccine Sales by Type (2019-2030)
9.1.3 Europe Newcastle Disease Vaccine Price by Type (2019-2030)
9.2 Europe Newcastle Disease Vaccine Market Size by Application
9.2.1 Europe Newcastle Disease Vaccine Revenue by Application (2019-2030)
9.2.2 Europe Newcastle Disease Vaccine Sales by Application (2019-2030)
9.2.3 Europe Newcastle Disease Vaccine Price by Application (2019-2030)
9.3 Europe Newcastle Disease Vaccine Market Size by Country
9.3.1 Europe Newcastle Disease Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Newcastle Disease Vaccine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Newcastle Disease Vaccine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Newcastle Disease Vaccine Market Size by Type
10.1.1 China Newcastle Disease Vaccine Revenue by Type (2019-2030)
10.1.2 China Newcastle Disease Vaccine Sales by Type (2019-2030)
10.1.3 China Newcastle Disease Vaccine Price by Type (2019-2030)
10.2 China Newcastle Disease Vaccine Market Size by Application
10.2.1 China Newcastle Disease Vaccine Revenue by Application (2019-2030)
10.2.2 China Newcastle Disease Vaccine Sales by Application (2019-2030)
10.2.3 China Newcastle Disease Vaccine Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Newcastle Disease Vaccine Market Size by Type
11.1.1 Asia Newcastle Disease Vaccine Revenue by Type (2019-2030)
11.1.2 Asia Newcastle Disease Vaccine Sales by Type (2019-2030)
11.1.3 Asia Newcastle Disease Vaccine Price by Type (2019-2030)
11.2 Asia Newcastle Disease Vaccine Market Size by Application
11.2.1 Asia Newcastle Disease Vaccine Revenue by Application (2019-2030)
11.2.2 Asia Newcastle Disease Vaccine Sales by Application (2019-2030)
11.2.3 Asia Newcastle Disease Vaccine Price by Application (2019-2030)
11.3 Asia Newcastle Disease Vaccine Market Size by Country
11.3.1 Asia Newcastle Disease Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Newcastle Disease Vaccine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Newcastle Disease Vaccine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Newcastle Disease Vaccine Market Size by Type
12.1.1 MEALA Newcastle Disease Vaccine Revenue by Type (2019-2030)
12.1.2 MEALA Newcastle Disease Vaccine Sales by Type (2019-2030)
12.1.3 MEALA Newcastle Disease Vaccine Price by Type (2019-2030)
12.2 MEALA Newcastle Disease Vaccine Market Size by Application
12.2.1 MEALA Newcastle Disease Vaccine Revenue by Application (2019-2030)
12.2.2 MEALA Newcastle Disease Vaccine Sales by Application (2019-2030)
12.2.3 MEALA Newcastle Disease Vaccine Price by Application (2019-2030)
12.3 MEALA Newcastle Disease Vaccine Market Size by Country
12.3.1 MEALA Newcastle Disease Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Newcastle Disease Vaccine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Newcastle Disease Vaccine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Newcastle Disease Vaccine Value Chain Analysis
13.1.1 Newcastle Disease Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Newcastle Disease Vaccine Production Mode & Process
13.2 Newcastle Disease Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Newcastle Disease Vaccine Distributors
13.2.3 Newcastle Disease Vaccine Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
1.1 Product Definition
1.2 Newcastle Disease Vaccine Market by Type
1.2.1 Global Newcastle Disease Vaccine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Newcastle Disease Vaccine Market by Application
1.3.1 Global Newcastle Disease Vaccine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 NEWCASTLE DISEASE VACCINE MARKET DYNAMICS
2.1 Newcastle Disease Vaccine Industry Trends
2.2 Newcastle Disease Vaccine Industry Drivers
2.3 Newcastle Disease Vaccine Industry Opportunities and Challenges
2.4 Newcastle Disease Vaccine Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Newcastle Disease Vaccine Revenue Estimates and Forecasts (2019-2030)
3.2 Global Newcastle Disease Vaccine Revenue by Region
3.2.1 Global Newcastle Disease Vaccine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Newcastle Disease Vaccine Revenue by Region (2019-2024)
3.2.3 Global Newcastle Disease Vaccine Revenue by Region (2025-2030)
3.2.4 Global Newcastle Disease Vaccine Revenue Market Share by Region (2019-2030)
3.3 Global Newcastle Disease Vaccine Sales Estimates and Forecasts 2019-2030
3.4 Global Newcastle Disease Vaccine Sales by Region
3.4.1 Global Newcastle Disease Vaccine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Newcastle Disease Vaccine Sales by Region (2019-2024)
3.4.3 Global Newcastle Disease Vaccine Sales by Region (2025-2030)
3.4.4 Global Newcastle Disease Vaccine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Newcastle Disease Vaccine Revenue by Manufacturers
4.1.1 Global Newcastle Disease Vaccine Revenue by Manufacturers (2019-2024)
4.1.2 Global Newcastle Disease Vaccine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Newcastle Disease Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Newcastle Disease Vaccine Sales by Manufacturers
4.2.1 Global Newcastle Disease Vaccine Sales by Manufacturers (2019-2024)
4.2.2 Global Newcastle Disease Vaccine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Newcastle Disease Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Newcastle Disease Vaccine Sales Price by Manufacturers (2019-2024)
4.4 Global Newcastle Disease Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Newcastle Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Newcastle Disease Vaccine Manufacturers, Product Type & Application
4.7 Global Newcastle Disease Vaccine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Newcastle Disease Vaccine Market CR5 and HHI
4.8.2 2023 Newcastle Disease Vaccine Tier 1, Tier 2, and Tier
5 NEWCASTLE DISEASE VACCINE MARKET BY TYPE
5.1 Global Newcastle Disease Vaccine Revenue by Type
5.1.1 Global Newcastle Disease Vaccine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Newcastle Disease Vaccine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Newcastle Disease Vaccine Revenue Market Share by Type (2019-2030)
5.2 Global Newcastle Disease Vaccine Sales by Type
5.2.1 Global Newcastle Disease Vaccine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Newcastle Disease Vaccine Sales by Type (2019-2030) & (M Doses)
5.2.3 Global Newcastle Disease Vaccine Sales Market Share by Type (2019-2030)
5.3 Global Newcastle Disease Vaccine Price by Type
6 NEWCASTLE DISEASE VACCINE MARKET BY APPLICATION
6.1 Global Newcastle Disease Vaccine Revenue by Application
6.1.1 Global Newcastle Disease Vaccine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Newcastle Disease Vaccine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Newcastle Disease Vaccine Revenue Market Share by Application (2019-2030)
6.2 Global Newcastle Disease Vaccine Sales by Application
6.2.1 Global Newcastle Disease Vaccine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Newcastle Disease Vaccine Sales by Application (2019-2030) & (M Doses)
6.2.3 Global Newcastle Disease Vaccine Sales Market Share by Application (2019-2030)
6.3 Global Newcastle Disease Vaccine Price by Application
7 COMPANY PROFILES
7.1 Merial
7.1.1 Merial Comapny Information
7.1.2 Merial Business Overview
7.1.3 Merial Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Merial Newcastle Disease Vaccine Product Portfolio
7.1.5 Merial Recent Developments
7.2 CEVA
7.2.1 CEVA Comapny Information
7.2.2 CEVA Business Overview
7.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 CEVA Newcastle Disease Vaccine Product Portfolio
7.2.5 CEVA Recent Developments
7.3 QYH Biotech
7.3.1 QYH Biotech Comapny Information
7.3.2 QYH Biotech Business Overview
7.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 QYH Biotech Newcastle Disease Vaccine Product Portfolio
7.3.5 QYH Biotech Recent Developments
7.4 Ringpu Biology
7.4.1 Ringpu Biology Comapny Information
7.4.2 Ringpu Biology Business Overview
7.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
7.4.5 Ringpu Biology Recent Developments
7.5 Yebio
7.5.1 Yebio Comapny Information
7.5.2 Yebio Business Overview
7.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Yebio Newcastle Disease Vaccine Product Portfolio
7.5.5 Yebio Recent Developments
7.6 Harbin Veterinary Research Institute
7.6.1 Harbin Veterinary Research Institute Comapny Information
7.6.2 Harbin Veterinary Research Institute Business Overview
7.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
7.6.5 Harbin Veterinary Research Institute Recent Developments
7.7 Merck Animal Health
7.7.1 Merck Animal Health Comapny Information
7.7.2 Merck Animal Health Business Overview
7.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
7.7.5 Merck Animal Health Recent Developments
7.8 DHN
7.8.1 DHN Comapny Information
7.8.2 DHN Business Overview
7.8.3 DHN Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 DHN Newcastle Disease Vaccine Product Portfolio
7.8.5 DHN Recent Developments
7.9 Zoetis
7.9.1 Zoetis Comapny Information
7.9.2 Zoetis Business Overview
7.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Zoetis Newcastle Disease Vaccine Product Portfolio
7.9.5 Zoetis Recent Developments
7.10 ChengDu Tecbond
7.10.1 ChengDu Tecbond Comapny Information
7.10.2 ChengDu Tecbond Business Overview
7.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
7.10.5 ChengDu Tecbond Recent Developments
7.11 Elanco (Lohmann)
7.11.1 Elanco (Lohmann) Comapny Information
7.11.2 Elanco (Lohmann) Business Overview
7.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
7.11.5 Elanco (Lohmann) Recent Developments
7.12 FATRO
7.12.1 FATRO Comapny Information
7.12.2 FATRO Business Overview
7.12.3 FATRO Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 FATRO Newcastle Disease Vaccine Product Portfolio
7.12.5 FATRO Recent Developments
7.13 CAVAC
7.13.1 CAVAC Comapny Information
7.13.2 CAVAC Business Overview
7.13.3 CAVAC Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 CAVAC Newcastle Disease Vaccine Product Portfolio
7.13.5 CAVAC Recent Developments
7.14 Vaksindo
7.14.1 Vaksindo Comapny Information
7.14.2 Vaksindo Business Overview
7.14.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 Vaksindo Newcastle Disease Vaccine Product Portfolio
7.14.5 Vaksindo Recent Developments
8 NORTH AMERICA
8.1 North America Newcastle Disease Vaccine Market Size by Type
8.1.1 North America Newcastle Disease Vaccine Revenue by Type (2019-2030)
8.1.2 North America Newcastle Disease Vaccine Sales by Type (2019-2030)
8.1.3 North America Newcastle Disease Vaccine Price by Type (2019-2030)
8.2 North America Newcastle Disease Vaccine Market Size by Application
8.2.1 North America Newcastle Disease Vaccine Revenue by Application (2019-2030)
8.2.2 North America Newcastle Disease Vaccine Sales by Application (2019-2030)
8.2.3 North America Newcastle Disease Vaccine Price by Application (2019-2030)
8.3 North America Newcastle Disease Vaccine Market Size by Country
8.3.1 North America Newcastle Disease Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Newcastle Disease Vaccine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Newcastle Disease Vaccine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Newcastle Disease Vaccine Market Size by Type
9.1.1 Europe Newcastle Disease Vaccine Revenue by Type (2019-2030)
9.1.2 Europe Newcastle Disease Vaccine Sales by Type (2019-2030)
9.1.3 Europe Newcastle Disease Vaccine Price by Type (2019-2030)
9.2 Europe Newcastle Disease Vaccine Market Size by Application
9.2.1 Europe Newcastle Disease Vaccine Revenue by Application (2019-2030)
9.2.2 Europe Newcastle Disease Vaccine Sales by Application (2019-2030)
9.2.3 Europe Newcastle Disease Vaccine Price by Application (2019-2030)
9.3 Europe Newcastle Disease Vaccine Market Size by Country
9.3.1 Europe Newcastle Disease Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Newcastle Disease Vaccine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Newcastle Disease Vaccine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Newcastle Disease Vaccine Market Size by Type
10.1.1 China Newcastle Disease Vaccine Revenue by Type (2019-2030)
10.1.2 China Newcastle Disease Vaccine Sales by Type (2019-2030)
10.1.3 China Newcastle Disease Vaccine Price by Type (2019-2030)
10.2 China Newcastle Disease Vaccine Market Size by Application
10.2.1 China Newcastle Disease Vaccine Revenue by Application (2019-2030)
10.2.2 China Newcastle Disease Vaccine Sales by Application (2019-2030)
10.2.3 China Newcastle Disease Vaccine Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Newcastle Disease Vaccine Market Size by Type
11.1.1 Asia Newcastle Disease Vaccine Revenue by Type (2019-2030)
11.1.2 Asia Newcastle Disease Vaccine Sales by Type (2019-2030)
11.1.3 Asia Newcastle Disease Vaccine Price by Type (2019-2030)
11.2 Asia Newcastle Disease Vaccine Market Size by Application
11.2.1 Asia Newcastle Disease Vaccine Revenue by Application (2019-2030)
11.2.2 Asia Newcastle Disease Vaccine Sales by Application (2019-2030)
11.2.3 Asia Newcastle Disease Vaccine Price by Application (2019-2030)
11.3 Asia Newcastle Disease Vaccine Market Size by Country
11.3.1 Asia Newcastle Disease Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Newcastle Disease Vaccine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Newcastle Disease Vaccine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Newcastle Disease Vaccine Market Size by Type
12.1.1 MEALA Newcastle Disease Vaccine Revenue by Type (2019-2030)
12.1.2 MEALA Newcastle Disease Vaccine Sales by Type (2019-2030)
12.1.3 MEALA Newcastle Disease Vaccine Price by Type (2019-2030)
12.2 MEALA Newcastle Disease Vaccine Market Size by Application
12.2.1 MEALA Newcastle Disease Vaccine Revenue by Application (2019-2030)
12.2.2 MEALA Newcastle Disease Vaccine Sales by Application (2019-2030)
12.2.3 MEALA Newcastle Disease Vaccine Price by Application (2019-2030)
12.3 MEALA Newcastle Disease Vaccine Market Size by Country
12.3.1 MEALA Newcastle Disease Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Newcastle Disease Vaccine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Newcastle Disease Vaccine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Newcastle Disease Vaccine Value Chain Analysis
13.1.1 Newcastle Disease Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Newcastle Disease Vaccine Production Mode & Process
13.2 Newcastle Disease Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Newcastle Disease Vaccine Distributors
13.2.3 Newcastle Disease Vaccine Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
LIST OF TABLES
Table 1. Global Newcastle Disease Vaccine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Live Vaccines Major Manufacturers
Table 3. Killed Vaccines Major Manufacturers
Table 4. Global Newcastle Disease Vaccine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Chicken Major Manufacturers
Table 6. Duck & Goose Major Manufacturers
Table 7. Other Major Manufacturers
Table 8. Newcastle Disease Vaccine Industry Trends
Table 9. Newcastle Disease Vaccine Industry Drivers
Table 10. Newcastle Disease Vaccine Industry Opportunities and Challenges
Table 11. Newcastle Disease Vaccine Industry Restraints
Table 12. Global Newcastle Disease Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 13. Global Newcastle Disease Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 14. Global Newcastle Disease Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 15. Global Newcastle Disease Vaccine Revenue Market Share by Region (2019-2024)
Table 16. Global Newcastle Disease Vaccine Revenue Market Share by Region (2025-2030)
Table 17. Global Newcastle Disease Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 18. Global Newcastle Disease Vaccine Sales by Region (2019-2024) & (M Doses)
Table 19. Global Newcastle Disease Vaccine Sales by Region (2025-2030) & (M Doses)
Table 20. Global Newcastle Disease Vaccine Sales Market Share by Region (2019-2024)
Table 21. Global Newcastle Disease Vaccine Sales Market Share by Region (2025-2030)
Table 22. Global Newcastle Disease Vaccine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 23. Global Newcastle Disease Vaccine Revenue Market Share by Manufacturers (2019-2024)
Table 24. Global Newcastle Disease Vaccine Sales by Manufacturers (US$ Million) & (2019-2024)
Table 25. Global Newcastle Disease Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 26. Global Newcastle Disease Vaccine Sales Price (USD/K Doses) of Manufacturers (2019-2024)
Table 27. Global Newcastle Disease Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 28. Global Newcastle Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters
Table 29. Global Newcastle Disease Vaccine Manufacturers, Product Type & Application
Table 30. Global Newcastle Disease Vaccine Manufacturers Commercialization Time
Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Newcastle Disease Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 33. Global Newcastle Disease Vaccine Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 34. Global Newcastle Disease Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 35. Global Newcastle Disease Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 36. Global Newcastle Disease Vaccine Revenue Market Share by Type (2019-2024)
Table 37. Global Newcastle Disease Vaccine Revenue Market Share by Type (2025-2030)
Table 38. Global Newcastle Disease Vaccine Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 39. Global Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 40. Global Newcastle Disease Vaccine Sales by Type (2025-2030) & (M Doses)
Table 41. Global Newcastle Disease Vaccine Sales Market Share by Type (2019-2024)
Table 42. Global Newcastle Disease Vaccine Sales Market Share by Type (2025-2030)
Table 43. Global Newcastle Disease Vaccine Price by Type (2019-2024) & (USD/K Doses)
Table 44. Global Newcastle Disease Vaccine Price by Type (2025-2030) & (USD/K Doses)
Table 45. Global Newcastle Disease Vaccine Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Global Newcastle Disease Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 47. Global Newcastle Disease Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 48. Global Newcastle Disease Vaccine Revenue Market Share by Application (2019-2024)
Table 49. Global Newcastle Disease Vaccine Revenue Market Share by Application (2025-2030)
Table 50. Global Newcastle Disease Vaccine Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 51. Global Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 52. Global Newcastle Disease Vaccine Sales by Application (2025-2030) & (M Doses)
Table 53. Global Newcastle Disease Vaccine Sales Market Share by Application (2019-2024)
Table 54. Global Newcastle Disease Vaccine Sales Market Share by Application (2025-2030)
Table 55. Global Newcastle Disease Vaccine Price by Application (2019-2024) & (USD/K Doses)
Table 56. Global Newcastle Disease Vaccine Price by Application (2025-2030) & (USD/K Doses)
Table 57. Merial Company Information
Table 58. Merial Business Overview
Table 59. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 60. Merial Newcastle Disease Vaccine Product Portfolio
Table 61. Merial Recent Development
Table 62. CEVA Company Information
Table 63. CEVA Business Overview
Table 64. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 65. CEVA Newcastle Disease Vaccine Product Portfolio
Table 66. CEVA Recent Development
Table 67. QYH Biotech Company Information
Table 68. QYH Biotech Business Overview
Table 69. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 70. QYH Biotech Newcastle Disease Vaccine Product Portfolio
Table 71. QYH Biotech Recent Development
Table 72. Ringpu Biology Company Information
Table 73. Ringpu Biology Business Overview
Table 74. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 75. Ringpu Biology Newcastle Disease Vaccine Product Portfolio
Table 76. Ringpu Biology Recent Development
Table 77. Yebio Company Information
Table 78. Yebio Business Overview
Table 79. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 80. Yebio Newcastle Disease Vaccine Product Portfolio
Table 81. Yebio Recent Development
Table 82. Harbin Veterinary Research Institute Company Information
Table 83. Harbin Veterinary Research Institute Business Overview
Table 84. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 85. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
Table 86. Harbin Veterinary Research Institute Recent Development
Table 87. Merck Animal Health Company Information
Table 88. Merck Animal Health Business Overview
Table 89. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 90. Merck Animal Health Newcastle Disease Vaccine Product Portfolio
Table 91. Merck Animal Health Recent Development
Table 92. DHN Company Information
Table 93. DHN Business Overview
Table 94. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 95. DHN Newcastle Disease Vaccine Product Portfolio
Table 96. DHN Recent Development
Table 97. Zoetis Company Information
Table 98. Zoetis Business Overview
Table 99. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 100. Zoetis Newcastle Disease Vaccine Product Portfolio
Table 101. Zoetis Recent Development
Table 102. ChengDu Tecbond Company Information
Table 103. ChengDu Tecbond Business Overview
Table 104. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 105. ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
Table 106. ChengDu Tecbond Recent Development
Table 107. Elanco (Lohmann) Company Information
Table 108. Elanco (Lohmann) Business Overview
Table 109. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 110. Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
Table 111. Elanco (Lohmann) Recent Development
Table 112. FATRO Company Information
Table 113. FATRO Business Overview
Table 114. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 115. FATRO Newcastle Disease Vaccine Product Portfolio
Table 116. FATRO Recent Development
Table 117. CAVAC Company Information
Table 118. CAVAC Business Overview
Table 119. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 120. CAVAC Newcastle Disease Vaccine Product Portfolio
Table 121. CAVAC Recent Development
Table 122. Vaksindo Company Information
Table 123. Vaksindo Business Overview
Table 124. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 125. Vaksindo Newcastle Disease Vaccine Product Portfolio
Table 126. Vaksindo Recent Development
Table 127. North America Newcastle Disease Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 128. North America Newcastle Disease Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 129. North America Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 130. North America Newcastle Disease Vaccine Sales by Type (2025-2030) & (M Doses)
Table 131. North America Newcastle Disease Vaccine Sales Price by Type (2019-2024) & (USD/K Doses)
Table 132. North America Newcastle Disease Vaccine Sales Price by Type (2025-2030) & (USD/K Doses)
Table 133. North America Newcastle Disease Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 134. North America Newcastle Disease Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 135. North America Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 136. North America Newcastle Disease Vaccine Sales by Application (2025-2030) & (M Doses)
Table 137. North America Newcastle Disease Vaccine Sales Price by Application (2019-2024) & (USD/K Doses)
Table 138. North America Newcastle Disease Vaccine Sales Price by Application (2025-2030) & (USD/K Doses)
Table 139. North America Newcastle Disease Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 140. North America Newcastle Disease Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 141. North America Newcastle Disease Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 142. North America Newcastle Disease Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 143. North America Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 144. North America Newcastle Disease Vaccine Sales by Country (2025-2030) & (M Doses)
Table 145. North America Newcastle Disease Vaccine Sales Price by Country (2019-2024) & (USD/K Doses)
Table 146. North America Newcastle Disease Vaccine Sales Price by Country (2025-2030) & (USD/K Doses)
Table 147. US Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Table 148. Canada Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Table 149. Europe Newcastle Disease Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 150. Europe Newcastle Disease Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 151. Europe Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 152. Europe Newcastle Disease Vaccine Sales by Type (2025-2030) & (M Doses)
Table 153. Europe Newcastle Disease Vaccine Sales Price by Type (2019-2024) & (USD/K Doses)
Table 154. Europe Newcastle Disease Vaccine Sales Price by Type (2025-2030) & (USD/K Doses)
Table 155. Europe Newcastle Disease Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 156. Europe Newcastle Disease Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 157. Europe Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 158. Europe Newcastle Disease Vaccine Sales by Application (2025-2030) & (M Doses)
Table 159. Europe Newcastle Disease Vaccine Sales Price by Application (2019-2024) & (USD/K Doses)
Table 160. Europe Newcastle Disease Vaccine Sales Price by Application (2025-2030) & (USD/K Doses)
Table 161. Europe Newcastle Disease Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 162. Europe Newcastle Disease Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 163. Europe Newcastle Disease Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 164. Europe Newcastle Disease Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 165. Europe Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 166. Europe Newcastle Disease Vaccine Sales by Country (2025-2030) & (M Doses)
Table 167. Europe Newcastle Disease Vaccine Sales Price by Country (2019-2024) & (USD/K Doses)
Table 168. Europe Newcastle Disease Vaccine Sales Price by Country (2025-2030) & (USD/K Doses)
Table 169. Germany Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Table 170. France Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Table 171. Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Table 172. Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Table 173. Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Table 174. China Newcastle Disease Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 175. China Newcastle Disease Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 176. China Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 177. China Newcastle Disease Vaccine Sales by Type (2025-2030) & (M Doses)
Table 178. China Newcastle Disease Vaccine Sales Price by Type (2019-2024) & (USD/K Doses)
Table 179. China Newcastle Disease Vaccine Sales Price by Type (2025-2030) & (USD/K Doses)
Table 180. China Newcastle Disease Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 181. China Newcastle Disease Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 182. China Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 183. China Newcastle Disease Vaccine Sales by Application (2025-2030) & (M Doses)
Table 184. China Newcastle Disease Vaccine Sales Price by Application (2019-2024) & (USD/K Doses)
Table 185. China Newcastle Disease Vaccine Sales Price by Application (2025-2030) & (USD/K Doses)
Table 186. Asia Newcastle Disease Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 187. Asia Newcastle Disease Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 188. Asia Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 189. Asia Newcastle Disease Vaccine Sales by Type (2025-2030) & (M Doses)
Table 190. Asia Newcastle Disease Vaccine Sales Price by Type (2019-2024) & (USD/K Doses)
Table 191. Asia Newcastle Disease Vaccine Sales Price by Type (2025-2030) & (USD/K Doses)
Table 192. Asia Newcastle Disease Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 193. Asia Newcastle Disease Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 194. Asia Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 195. Asia Newcastle Disease Vaccine Sales by Application (2025-2030) & (M Doses)
Table 196. Asia Newcastle Disease Vaccine Sales Price by Application (2019-2024) & (USD/K Doses)
Table 197. Asia Newcastle Disease Vaccine Sales Price by Application (2025-2030) & (USD/K Doses)
Table 198. Asia Newcastle Disease Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 199. Asia Newcastle Disease Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 200. Asia Newcastle Disease Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 201. Asia Newcastle Disease Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 202. Asia Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 1. Global Newcastle Disease Vaccine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Live Vaccines Major Manufacturers
Table 3. Killed Vaccines Major Manufacturers
Table 4. Global Newcastle Disease Vaccine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Chicken Major Manufacturers
Table 6. Duck & Goose Major Manufacturers
Table 7. Other Major Manufacturers
Table 8. Newcastle Disease Vaccine Industry Trends
Table 9. Newcastle Disease Vaccine Industry Drivers
Table 10. Newcastle Disease Vaccine Industry Opportunities and Challenges
Table 11. Newcastle Disease Vaccine Industry Restraints
Table 12. Global Newcastle Disease Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 13. Global Newcastle Disease Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 14. Global Newcastle Disease Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 15. Global Newcastle Disease Vaccine Revenue Market Share by Region (2019-2024)
Table 16. Global Newcastle Disease Vaccine Revenue Market Share by Region (2025-2030)
Table 17. Global Newcastle Disease Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 18. Global Newcastle Disease Vaccine Sales by Region (2019-2024) & (M Doses)
Table 19. Global Newcastle Disease Vaccine Sales by Region (2025-2030) & (M Doses)
Table 20. Global Newcastle Disease Vaccine Sales Market Share by Region (2019-2024)
Table 21. Global Newcastle Disease Vaccine Sales Market Share by Region (2025-2030)
Table 22. Global Newcastle Disease Vaccine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 23. Global Newcastle Disease Vaccine Revenue Market Share by Manufacturers (2019-2024)
Table 24. Global Newcastle Disease Vaccine Sales by Manufacturers (US$ Million) & (2019-2024)
Table 25. Global Newcastle Disease Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 26. Global Newcastle Disease Vaccine Sales Price (USD/K Doses) of Manufacturers (2019-2024)
Table 27. Global Newcastle Disease Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 28. Global Newcastle Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters
Table 29. Global Newcastle Disease Vaccine Manufacturers, Product Type & Application
Table 30. Global Newcastle Disease Vaccine Manufacturers Commercialization Time
Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Newcastle Disease Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 33. Global Newcastle Disease Vaccine Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 34. Global Newcastle Disease Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 35. Global Newcastle Disease Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 36. Global Newcastle Disease Vaccine Revenue Market Share by Type (2019-2024)
Table 37. Global Newcastle Disease Vaccine Revenue Market Share by Type (2025-2030)
Table 38. Global Newcastle Disease Vaccine Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 39. Global Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 40. Global Newcastle Disease Vaccine Sales by Type (2025-2030) & (M Doses)
Table 41. Global Newcastle Disease Vaccine Sales Market Share by Type (2019-2024)
Table 42. Global Newcastle Disease Vaccine Sales Market Share by Type (2025-2030)
Table 43. Global Newcastle Disease Vaccine Price by Type (2019-2024) & (USD/K Doses)
Table 44. Global Newcastle Disease Vaccine Price by Type (2025-2030) & (USD/K Doses)
Table 45. Global Newcastle Disease Vaccine Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Global Newcastle Disease Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 47. Global Newcastle Disease Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 48. Global Newcastle Disease Vaccine Revenue Market Share by Application (2019-2024)
Table 49. Global Newcastle Disease Vaccine Revenue Market Share by Application (2025-2030)
Table 50. Global Newcastle Disease Vaccine Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 51. Global Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 52. Global Newcastle Disease Vaccine Sales by Application (2025-2030) & (M Doses)
Table 53. Global Newcastle Disease Vaccine Sales Market Share by Application (2019-2024)
Table 54. Global Newcastle Disease Vaccine Sales Market Share by Application (2025-2030)
Table 55. Global Newcastle Disease Vaccine Price by Application (2019-2024) & (USD/K Doses)
Table 56. Global Newcastle Disease Vaccine Price by Application (2025-2030) & (USD/K Doses)
Table 57. Merial Company Information
Table 58. Merial Business Overview
Table 59. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 60. Merial Newcastle Disease Vaccine Product Portfolio
Table 61. Merial Recent Development
Table 62. CEVA Company Information
Table 63. CEVA Business Overview
Table 64. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 65. CEVA Newcastle Disease Vaccine Product Portfolio
Table 66. CEVA Recent Development
Table 67. QYH Biotech Company Information
Table 68. QYH Biotech Business Overview
Table 69. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 70. QYH Biotech Newcastle Disease Vaccine Product Portfolio
Table 71. QYH Biotech Recent Development
Table 72. Ringpu Biology Company Information
Table 73. Ringpu Biology Business Overview
Table 74. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 75. Ringpu Biology Newcastle Disease Vaccine Product Portfolio
Table 76. Ringpu Biology Recent Development
Table 77. Yebio Company Information
Table 78. Yebio Business Overview
Table 79. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 80. Yebio Newcastle Disease Vaccine Product Portfolio
Table 81. Yebio Recent Development
Table 82. Harbin Veterinary Research Institute Company Information
Table 83. Harbin Veterinary Research Institute Business Overview
Table 84. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 85. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
Table 86. Harbin Veterinary Research Institute Recent Development
Table 87. Merck Animal Health Company Information
Table 88. Merck Animal Health Business Overview
Table 89. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 90. Merck Animal Health Newcastle Disease Vaccine Product Portfolio
Table 91. Merck Animal Health Recent Development
Table 92. DHN Company Information
Table 93. DHN Business Overview
Table 94. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 95. DHN Newcastle Disease Vaccine Product Portfolio
Table 96. DHN Recent Development
Table 97. Zoetis Company Information
Table 98. Zoetis Business Overview
Table 99. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 100. Zoetis Newcastle Disease Vaccine Product Portfolio
Table 101. Zoetis Recent Development
Table 102. ChengDu Tecbond Company Information
Table 103. ChengDu Tecbond Business Overview
Table 104. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 105. ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
Table 106. ChengDu Tecbond Recent Development
Table 107. Elanco (Lohmann) Company Information
Table 108. Elanco (Lohmann) Business Overview
Table 109. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 110. Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
Table 111. Elanco (Lohmann) Recent Development
Table 112. FATRO Company Information
Table 113. FATRO Business Overview
Table 114. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 115. FATRO Newcastle Disease Vaccine Product Portfolio
Table 116. FATRO Recent Development
Table 117. CAVAC Company Information
Table 118. CAVAC Business Overview
Table 119. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 120. CAVAC Newcastle Disease Vaccine Product Portfolio
Table 121. CAVAC Recent Development
Table 122. Vaksindo Company Information
Table 123. Vaksindo Business Overview
Table 124. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 125. Vaksindo Newcastle Disease Vaccine Product Portfolio
Table 126. Vaksindo Recent Development
Table 127. North America Newcastle Disease Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 128. North America Newcastle Disease Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 129. North America Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 130. North America Newcastle Disease Vaccine Sales by Type (2025-2030) & (M Doses)
Table 131. North America Newcastle Disease Vaccine Sales Price by Type (2019-2024) & (USD/K Doses)
Table 132. North America Newcastle Disease Vaccine Sales Price by Type (2025-2030) & (USD/K Doses)
Table 133. North America Newcastle Disease Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 134. North America Newcastle Disease Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 135. North America Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 136. North America Newcastle Disease Vaccine Sales by Application (2025-2030) & (M Doses)
Table 137. North America Newcastle Disease Vaccine Sales Price by Application (2019-2024) & (USD/K Doses)
Table 138. North America Newcastle Disease Vaccine Sales Price by Application (2025-2030) & (USD/K Doses)
Table 139. North America Newcastle Disease Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 140. North America Newcastle Disease Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 141. North America Newcastle Disease Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 142. North America Newcastle Disease Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 143. North America Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 144. North America Newcastle Disease Vaccine Sales by Country (2025-2030) & (M Doses)
Table 145. North America Newcastle Disease Vaccine Sales Price by Country (2019-2024) & (USD/K Doses)
Table 146. North America Newcastle Disease Vaccine Sales Price by Country (2025-2030) & (USD/K Doses)
Table 147. US Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Table 148. Canada Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Table 149. Europe Newcastle Disease Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 150. Europe Newcastle Disease Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 151. Europe Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 152. Europe Newcastle Disease Vaccine Sales by Type (2025-2030) & (M Doses)
Table 153. Europe Newcastle Disease Vaccine Sales Price by Type (2019-2024) & (USD/K Doses)
Table 154. Europe Newcastle Disease Vaccine Sales Price by Type (2025-2030) & (USD/K Doses)
Table 155. Europe Newcastle Disease Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 156. Europe Newcastle Disease Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 157. Europe Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 158. Europe Newcastle Disease Vaccine Sales by Application (2025-2030) & (M Doses)
Table 159. Europe Newcastle Disease Vaccine Sales Price by Application (2019-2024) & (USD/K Doses)
Table 160. Europe Newcastle Disease Vaccine Sales Price by Application (2025-2030) & (USD/K Doses)
Table 161. Europe Newcastle Disease Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 162. Europe Newcastle Disease Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 163. Europe Newcastle Disease Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 164. Europe Newcastle Disease Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 165. Europe Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 166. Europe Newcastle Disease Vaccine Sales by Country (2025-2030) & (M Doses)
Table 167. Europe Newcastle Disease Vaccine Sales Price by Country (2019-2024) & (USD/K Doses)
Table 168. Europe Newcastle Disease Vaccine Sales Price by Country (2025-2030) & (USD/K Doses)
Table 169. Germany Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Table 170. France Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Table 171. Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Table 172. Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Table 173. Newcastle Disease Vaccine Revenue (2019-2030) & (US$ Million)
Table 174. China Newcastle Disease Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 175. China Newcastle Disease Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 176. China Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 177. China Newcastle Disease Vaccine Sales by Type (2025-2030) & (M Doses)
Table 178. China Newcastle Disease Vaccine Sales Price by Type (2019-2024) & (USD/K Doses)
Table 179. China Newcastle Disease Vaccine Sales Price by Type (2025-2030) & (USD/K Doses)
Table 180. China Newcastle Disease Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 181. China Newcastle Disease Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 182. China Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 183. China Newcastle Disease Vaccine Sales by Application (2025-2030) & (M Doses)
Table 184. China Newcastle Disease Vaccine Sales Price by Application (2019-2024) & (USD/K Doses)
Table 185. China Newcastle Disease Vaccine Sales Price by Application (2025-2030) & (USD/K Doses)
Table 186. Asia Newcastle Disease Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 187. Asia Newcastle Disease Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 188. Asia Newcastle Disease Vaccine Sales by Type (2019-2024) & (M Doses)
Table 189. Asia Newcastle Disease Vaccine Sales by Type (2025-2030) & (M Doses)
Table 190. Asia Newcastle Disease Vaccine Sales Price by Type (2019-2024) & (USD/K Doses)
Table 191. Asia Newcastle Disease Vaccine Sales Price by Type (2025-2030) & (USD/K Doses)
Table 192. Asia Newcastle Disease Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 193. Asia Newcastle Disease Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 194. Asia Newcastle Disease Vaccine Sales by Application (2019-2024) & (M Doses)
Table 195. Asia Newcastle Disease Vaccine Sales by Application (2025-2030) & (M Doses)
Table 196. Asia Newcastle Disease Vaccine Sales Price by Application (2019-2024) & (USD/K Doses)
Table 197. Asia Newcastle Disease Vaccine Sales Price by Application (2025-2030) & (USD/K Doses)
Table 198. Asia Newcastle Disease Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 199. Asia Newcastle Disease Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 200. Asia Newcastle Disease Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 201. Asia Newcastle Disease Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 202. Asia Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
